Zhuhai Trinomab Pharmaceutical Co., Ltd.

This study is tracking 10,000 people who get a new tetanus shot (Siltartoxatug) after an injury. The main goal is to see how well it prevents tetanus infection over 90 days and to record any side effects. It's a large, real-world registry that observes outcomes rather than testin…